CDC42 and breast carcinoma: Of the fourteen genes for which we found suitable germline genetic instruments, two—RHOD and CDC42—showed evidence of a link with breast cancer risk with the evidence being stronger for RHOD. The expression level of RHOD and CDC42 demonstrated positive and inverse effects on overall breast cancer, respectively.